Goal 3 B.V. ENABLING data-driven decisions to unburden health workers & save lives

Brief description of journey so far
Founded in 2019. First prototype and pilot in 2020. Leveraged EU-grant-funding to develop MVP, launched 2023. Achieved a 42% reduction in mortality over 18 months.

Brief description of core product/service
The IMPALA system uses innovative, data-driven technology for monitoring of vital signs, with real-time alerts for healthcare providers, allowing for faster and more effective interventions.

A statement on your current traction
Installed in 11 hospitals in Malawi, Rwanda and Tanzania (167 IMPALA’s) as per September 2024. A sales funnel of >1,000 IMPALA’s for 2025.

The company’s vision, goals & strategy
By delivering an unprecedented cost-effective platform solution against child-mortality we will become the standard-of-care and save millions of lives starting in Africa, expanding globally.

Sectors HealthTech, Medical equipment and supplies
Location 's-Hertogenbosch, Netherlands
Stage Sign in to view details
Markets Sign in to view details
Customer model Sign in to view details
Revenue Sign in to view details
Contact Sign in to view details
Social media